Additional information
| Specialty | |
|---|---|
| Dosage | |
| Form | |
| Presentation | |
| Primary packaging | |
| Specification | |
| DCI | |
| Classement VEIC | |
| Therapeutic class | |
| Sub Class | |
| Laboratory | |
| CHART | |
| The duration of the conversation | |
| Generic / Princeps | |
| AMM | |
| Date AMM | |
| Range |
RIVA 20MG BOX OF 30
Prevention of cerebrovascular accidents (CVA) and systemic embolisms in adult patients with non-valvular atrial fibrillation and presenting one or more risk factors (s), such as congestive heart failure, high blood pressure, age> = 75 years, diabetes, history of stroke or transient ischemic attack. Treatment of deep vein thrombosis (DVT) and pulmonary embolism, and prevention of recurrence in the form of DVT and PE in adults.
